Changzhou Qianhong Biopharma Co Ltd (002550) — Cash Flow-to-Debt Ratio
Changzhou Qianhong Biopharma Co Ltd (002550) has a Cash Flow-to-Debt Ratio of 0.61x as of September 2025, meaning its operating cash flow of CN¥156.34 Million could theoretically repay 1% of its total liabilities (CN¥255.86 Million) in one year. See Changzhou Qianhong Biopharma Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Changzhou Qianhong Biopharma Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Changzhou Qianhong Biopharma Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Changzhou Qianhong Biopharma Co Ltd cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Changzhou Qianhong Biopharma Co Ltd. Check 002550 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.13x | CN¥361.36 Million | CN¥320.64 Million | ▼ -31.3% |
| 2024 | 1.64x | CN¥514.71 Million | CN¥313.87 Million | ▼ -10.2% |
| 2023 | 1.83x | CN¥533.33 Million | CN¥292.17 Million | ▲ +1051.4% |
| 2022 | -0.19x | CN¥-71.47 Million | CN¥372.53 Million | ▼ -172.3% |
| 2021 | 0.27x | CN¥103.56 Million | CN¥390.24 Million | ▼ -67.7% |
| 2020 | 0.82x | CN¥317.28 Million | CN¥386.35 Million | ▲ +205.8% |
| 2019 | 0.27x | CN¥161.55 Million | CN¥601.65 Million | ▲ +575.5% |
| 2018 | 0.04x | CN¥25.45 Million | CN¥640.11 Million | ▼ -73.4% |
| 2017 | 0.15x | CN¥88.52 Million | CN¥591.41 Million | ▼ -58.7% |
| 2016 | 0.36x | CN¥221.01 Million | CN¥609.33 Million | ▼ -31.8% |
| 2015 | 0.53x | CN¥286.50 Million | CN¥538.67 Million | ▼ -62.4% |
| 2014 | 1.42x | CN¥252.01 Million | CN¥178.06 Million | ▼ -15.5% |
| 2013 | 1.68x | CN¥160.47 Million | CN¥95.77 Million | ▼ -50.9% |
| 2012 | 3.41x | CN¥199.82 Million | CN¥58.54 Million | ▲ +102.4% |
| 2011 | 1.69x | CN¥146.82 Million | CN¥87.07 Million | ▲ +32.5% |
| 2010 | 1.27x | CN¥171.51 Million | CN¥134.75 Million | ▲ +4323.2% |
| 2009 | 0.03x | CN¥8.35 Million | CN¥290.19 Million | ▼ -90.8% |
| 2008 | 0.31x | CN¥54.36 Million | CN¥173.75 Million | ▼ -33.1% |
| 2007 | 0.47x | CN¥35.99 Million | CN¥76.95 Million | — |